Growth Metrics

Mannkind (MNKD) Share-based Compensation Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -34.72%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 4.80%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 10.78%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.55%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 20.65%
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn 20.87%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 20.87%
Dec 31, 2025 38.98%
Sep 30, 2025 6.03%
Jun 30, 2025 19.36%
Mar 31, 2025 24.27%
Dec 31, 2024 22.56%
Sep 30, 2024 18.03%
Jun 30, 2024 17.86%
Mar 31, 2024 26.15%
Dec 31, 2023 26.05%
Sep 30, 2023 52.63%
Jun 30, 2023 36.69%
Mar 31, 2023 47.98%
Dec 31, 2022 42.84%
Sep 30, 2022 30.23%
Jun 30, 2022 19.86%
Mar 31, 2022 41.09%
Dec 31, 2021 40.39%
Sep 30, 2021 26.73%
Jun 30, 2021 21.13%
Mar 31, 2021 -0.14%
Dec 31, 2020 20.66%
Sep 30, 2020 1.24%
Jun 30, 2020 20.46%
Mar 31, 2020 -3.80%
Dec 31, 2019 -3.93%
Sep 30, 2019 2.97%
Jun 30, 2019 23.75%
Mar 31, 2019 -8.40%
Dec 31, 2018 -21.35%
Sep 30, 2018 -15.62%
Jun 30, 2018 7.56%
Mar 31, 2018 -1.01%
Dec 31, 2017 -16.58%
Sep 30, 2017 31.20%
Jun 30, 2017 -68.67%
Mar 31, 2017 -37.54%
Dec 31, 2016 -58.32%
Sep 30, 2016 -54.50%
Jun 30, 2016 -48.93%
Mar 31, 2016 -36.96%
Dec 31, 2015 -12.65%
Sep 30, 2015 -12.04%
Jun 30, 2015 -16.71%
Mar 31, 2015 -11.38%
Dec 31, 2014 -16.27%
Sep 30, 2014 -51.15%
Jun 30, 2014 173.21%
Mar 31, 2014 24.29%
Dec 31, 2013 83.76%
Sep 30, 2013 68.41%